Some studies with human tissue specimens indicate that DR5 is overexpressed in several cancer types and significantly correlated with more aggressive tumor behavior and poor survival of cancer patients (e.g., with breast, lung or renal cell cancer) [8–10]. Here, TNFRSF10B is linked to cancer.